0QND.L

Bachem Holding AG [0QND.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

0QND.L Stock Summary

Top 10 Correlated ETFs

0QND.L

Top 10 Correlated Stocks

0QND.L

In the News

0QND.L Financial details

Company Rating
-
Market Cap
6.05B
Income
212.54M
Revenue
1.11B
Book val./share
-
Cash/share
-
Dividend
0.75
Dividend %
1.22%
Employees
2.01K
Optionable
No
Shortable
Yes
Earnings
25 Jul 2024
P/E
46.9
Forward P/E
-
PEG
4.31
P/S
8.62
P/B
3.69
P/C
-
P/FCF
-78.52
Quick Ratio
2.1
Current Ratio
3.89
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.86
EPS next Y
-
EPS next Q
-
EPS this Y
9.49%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
13.97%
Revenue last 5Y
12.97%
Revenue Q/Q
40.69%
EPS Q/Q
123.91%
-
-
-
-
SMA20
-8.52%
SMA50
-14.68%
SMA100
-28.29%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
8%
ROC
0.08%
Gross Margin
30%
Oper. Margin
21%
Profit Margin
18%
Payout
57%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
54.7-105.3
52W High
-51.89%
52W Low
-6.44%
RSI
52.5
Rel Volume
0.05
Avg Volume
27.19K
Volume
1.33K
Perf Week
7.35%
Perf Month
-7.89%
Perf Quarter
-27.71%
Perf Half Y
-28.84%
-
-
-
-
Beta
0.694
-
-
Volatility
1.14%, 3.04%
Prev Close
0.52%
Price
50.52
Change
0.44%

0QND.L Financial Performance

0QND.L Dividend History

0QND.L Frequently Asked Questions

What is Bachem Holding AG stock symbol ?

Bachem Holding AG is a CH stock and trading under the symbol 0QND.L

What is Bachem Holding AG stock quote today ?

Bachem Holding AG stock price is $50.52 today.

Is Bachem Holding AG stock public?

Yes, Bachem Holding AG is a publicly traded company.

Something similar

Top by Market Cap
TSLA
AAPL
VOO
CMC.DE
ABEC.DE
Top Correlated ETFs
2B70.DE
EHLT.DE
EMEC.DE
ESIH.DE
LHTC.DE
Top Correlated Stocks
BANB.SW
CAP.PA
RF.PA
RAND.AS
RXL.PA
Similar Market Cap
TGIRX
6435.TWO
ESGRP
2102.TW
002674.SZ

Company Profile

Healthcare Medical - Pharmaceuticals
  • Volume Average 27.19K
  • Market Capitalization 6.05B
  • Employee 2.01K
  • CEO Mr. Thomas Meier
  • Headquarters Bubendorf,CH
  • IPO Date 2015-12-03
  • Website https://www.bachem.com

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.